日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2

接受靶向 FLT3、IDH1 或 IDH2 的酪氨酸激酶抑制剂 (TKI) 治疗的急性髓系白血病患者的健康差异

Espinoza-Gutarra, Manuel R; Jarrett, Brooke A; Wang, Xiaoliang; Afghahi, Anosheh; Bae, Sejong

Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis

卡非佐米在复发或难治性多发性骨髓瘤中的处方模式和疗效:一项真实世界分析

Dong, Sharlene; Banerjee, Rahul; Khan, Adeel M; Wang, Mengru; Wang, Xiaoliang; Afghahi, Anosheh; Afrough, Aimaz; Janakiram, Murali; Wang, Bo; Cowan, Andrew J; Sperling, Adam S; Anderson, Larry D Jr; Rajkumar, S Vincent; Kaur, Gurbakhash

Correction: Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice

更正:真实世界实践中基于BRCA1/2和瘢痕组织HRD特征的卵巢癌患者接受PARP抑制剂维持治疗的有效性

Richardson, Debra L; Quintanilha, Julia C F; Danziger, Natalie; Li, Gerald; Sokol, Ethan; Schrock, Alexa B; Ebot, Ericka; Bhardwaj, Neeru; Norris, Tanesha; Afghahi, Anosheh; Frachioni, Anthony; Washington, Christina; Dockery, Lauren; Elvin, Julia; Graf, Ryon P; Moore, Kathleen N

303. PATIENT AND CLINICIAN ACCEPTANCE OF RECENT TECHNOLOGICAL ADVANCES IN THE THERAPEUTIC MONITORING OF LITHIUM

303. 患者和临床医生对锂治疗监测领域最新技术进步的接受度

Northrop, Anna; Christofferson, Anika; Umashankar, Saumya; Melisko, Michelle; Castillo, Paolo; Brown, Thelma; Heditsian, Diane; Brain, Susie; Simmons, Carol; Hieken, Tina; Ruddy, Kathryn J; Mainor, Candace; Afghahi, Anosheh; Tevis, Sarah; Blaes, Anne; Kang, Irene; Asare, Adam; Esserman, Laura; Hershman, Dawn L; Basu, Amrita; Dodd, S; Pedraza-Sanabria, S; Paredes Castro, A M; Williams, L J; Giraldo-Cadavid, L F; Bustos, R H

Investigation of the Effects of Plastic, Pottery, and Wooden Containers on the Microbial, Chemical, Sensory Quality, and Shelf Life of Sturgeon (Acipenseridae) Gut Sauce

塑料、陶器和木制容器对鲟鱼(Acipenseridae)肠酱的微生物、化学、感官品质和保质期的影响研究

Seifzadeh, Mina; Koochakian Sabour, Anosheh; Raoufi, Ali

Comparing Appetite and Dietary Intake Responses to Resistance Exercise in Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy Versus Individuals Without Cancer: A Secondary Analysis

比较接受辅助内分泌治疗的乳腺癌幸存者与未患癌症个体在进行阻力运动后食欲和膳食摄入反应的二次分析

Purcell, Sarah A; Halliday, Tanya M; Melanson, Edward L; Afghahi, Anosheh; Borges, Virginia F; Sinelli, Isabella; Cornier, Marc-Andre

Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice

在真实世界实践中,基于BRCA1/2和瘢痕组织HRD特征的卵巢癌患者接受PARP抑制剂维持治疗的疗效

Richardson, Debra L; Quintanilha, Julia C F; Danziger, Natalie; Li, Gerald; Sokol, Ethan; Schrock, Alexa B; Ebot, Ericka; Bhardwaj, Neeru; Norris, Tanesha; Afghahi, Anosheh; Frachioni, Anthony; Washington, Christina; Dockery, Lauren; Elvin, Julia; Graf, Ryon P; Moore, Kathleen N

Characterizing informational needs and information seeking behavior of patients with breast cancer

描述乳腺癌患者的信息需求和信息寻求行为

Ludwigson, Abigail; Huynh, Victoria; Vemuru, Sudheer; Romandetti, Karina; Fisher, Christine; Coons, Helen L; Pettigrew, Jessica; Hampanda, Karen; Kaoutzanis, Christodoulos; Ahrendt, Gretchen; Afghahi, Anosheh; Stewart, Camille; Tevis, Sarah

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer

氟维司群联合恩扎卢胺治疗ER+/HER2-晚期乳腺癌的II期临床试验

Elias, Anthony D; Spoelstra, Nicole S; Staley, Alyse W; Sams, Sharon; Crump, Lyndsey S; Vidal, Gregory A; Borges, Virginia F; Kabos, Peter; Diamond, Jennifer R; Shagisultanova, Elena; Afghahi, Anosheh; Mayordomo, Jose; McSpadden, Tessa; Crawford, Gloria; D'Alessandro, Angelo; Zolman, Kathryn L; van Bokhoven, Adrie; Zhuang, Yonghua; Gallagher, Rosa I; Wulfkuhle, Julia D; Petricoin Iii, Emanuel F; Gao, Dexiang; Richer, Jennifer K

ROS Homeostasis and Antioxidants in the Halophytic Plants and Seeds

盐生植物和种子中的活性氧稳态和抗氧化剂

Pirasteh-Anosheh, Hadi; Samadi, Maryam; Kazemeini, Seyed Abdolreza; Ozturk, Munir; Ludwiczak, Agnieszka; Piernik, Agnieszka